News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
John Houston: Thanks for the great write up on the exciting events happening at Arvinas!
Photo of John Houston from Hartford Business Journal/LinkedIn
Jan 27, 2024, 22:42

John Houston: Thanks for the great write up on the exciting events happening at Arvinas!

John Houston, Chairperson, CEO and President at Arvinas (NASDAQ ARVN), shared the following post by Hartford Business Journal on LinkedIn, adding the following:

“Thanks for the great write up on the exciting events happening at Arvinas!”

Quoting Hartford Business Journal:

“With a recent $350 million fundraise, New Haven biotech Arvinas says it’s financed through at least 2027 to pursue bringing its cancer-fighting drugs to market.”

Read further.
Source: John Houston/LinkedIn and Hartford Business Journal/LinkedIn

Arvinas Biotechnology cancer Hartford Business Journal John Houston OncoDaily Oncology
Special Coverage
Blog
Apr 6, 2025, 17:46
Fifth Eye joins CancerX 2025 Accelerator
Blog
Apr 6, 2025, 17:36
Isabel Mestres: Kochi could officially join City Cancer Challenge
Blog
Apr 6, 2025, 17:24
Zorana Maravic speaking at the Amsterdam Biosimilar Medicines Conference - Digestive Cancers Europe
Science
Apr 6, 2025, 17:10
Christian Badr: Targeting SCD could be a promising strategy for developing more effective treatments for BCBM
Blog
Apr 6, 2025, 16:58
Giuseppe Lombardi: An important webinar with neuro-oncology experts on glioblastoma and meningioma
Blog
Apr 6, 2025, 16:46
The three modules of the SPCC-All.Can International online courses are available on-demand
Blog
Apr 6, 2025, 16:35
Wade Swenson: Zachary Schroeder’s experience with rural patients and families in his TEDx talk
Blog
Apr 6, 2025, 16:12
What does 'conquering cancer' mean to you professionally or personally? - Conquer Cancer, the ASCO Foundation
Blog
Apr 6, 2025, 16:08
Andrew M. Evens: Day 2 of the 22nd annual International Ultmann Chicago Lymphoma Symposium
Insight
Apr 6, 2025, 15:27
Ashish Kamat: Hybrid 3-Tier Bladder Cancer Grade - The Mutually Beneficial Marriage of 2 Grading Systems
Blog
Apr 6, 2025, 15:26
Lisa Lacasse: It’s been a little over a week since we celebrated the life of my dear friend, Keysha Brooks-Coley
Blog
Apr 6, 2025, 15:14
Lauren Averett Byers: S2409 is a landmark on the path to personalized SCLC care